1. Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer
   Hsin-Yuan Chen et al, 2023, Biomedicine & Pharmacotherapy CrossRef
2. CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses
   Masaki Imanishi et al, 2023, Journal of Pharmacological Sciences CrossRef
3. New Gene Variants Associated with the Risk of Chronic HBV Infection
   Mengjie Fan et al, 2020, Virologica Sinica CrossRef
4. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology
   Jialing Sun et al, 2024, Journal of Ethnopharmacology CrossRef
5. CA9 transcriptional expression determines prognosis and tumour grade in tongue squamous cell carcinoma patients
   Chenyu Guan et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
6. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma
   Guojun Huang et al, 2021, Future Oncology CrossRef
7. Sohlh2 alleviates malignancy of EOC cells under hypoxia via inhibiting the HIF1α/CA9 signaling pathway
   Xiaoli Zhang et al, 2020, Biological Chemistry CrossRef
8. GRK6 Depletion Induces HIF Activity in Lung Adenocarcinoma
   Sumei Yao et al, 2021, Frontiers in Oncology CrossRef
9. Mechanical confinement promotes heat resistance of hepatocellular carcinoma via SP1/IL4I1/AHR axis
   Guo-pei Zhang et al, 2023, Cell Reports Medicine CrossRef
10. Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer
    Larry Fliegel, 2020, From Malignant Transformation to Metastasis CrossRef
11. Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis
    Chengwei Liu et al, 2023, Heliyon CrossRef
12. Identification of a Subtype of Hepatocellular Carcinoma with Poor Prognosis Based on Expression of Genes within the Glucose Metabolic Pathway
    Xiaoli Zhang et al, 2019, Cancers CrossRef
13. Carbonic Anhydrase Isozymes as Diagnostic Biomarkers and Therapeutic Targets
    Seppo Parkkila, 2021, The Carbonic Anhydrases: Current and Emerging Therapeutic Targets CrossRef
14. Big Data-Based Identification of Multi-Gene Prognostic Signatures in Liver Cancer
    Meiliang Liu et al, 2020, Frontiers in Oncology CrossRef
15. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions
    Rendy Hosea et al, 2023, Cancers CrossRef
16. Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin
    Phuong Linh Nguyen et al, 2022, International Journal of Molecular Sciences CrossRef
17. Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis
    Boqin Wang et al, 2023, World Journal of Surgical Oncology CrossRef
18. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
    Maximilian Lennartz et al, 2023, Scientific Reports CrossRef
19. Fucoidan inhibits epithelial‑to‑mesenchymal transition via regulation of the HIF‑1α pathway in mammary cancer cells under hypoxia
    Weiwei Li et al, 2019, Oncology Letters CrossRef